FDA advisers vote in favor of boosters for older adults

Best Oddly Satisfying 2021-09-18

Views 53

Advisers to the U.S. Food and Drug Administration voted to recommend Pfizer COVID-19 vaccine booster shots for Americans 65 and older and those at high risk of severe illness, after overwhelmingly rejecting a call for broader approval.

#BoosterShot #FDA #COVID19 #News #Reuters #Pfizer

Show more

Download

Report form

RELATED VIDEOS

US FDA OKs booster shot of Pfizer vaccine; Pfizer says kids 5-11 can be vaccinated; Biden approves 500-M more COVID-19 vaccine doses for developing countries; Tokyo unveils library dedicated for author Haruki Murakami | via Meg Luna

play

US FDA OKs booster shot of Pfizer vaccine; Pfizer says kids 5-11 can be vaccinated; Biden approves 500-M more COVID-19 vaccine doses for developing countries; Tokyo unveils library dedicated for author Haruki Murakami | via Meg Luna

FDA authorizes limited Pfizer booster shots for COVID-19 vaccines

play

FDA authorizes limited Pfizer booster shots for COVID-19 vaccines

2nd booster dose ng Pfizer-BioNTech at Moderna COVID-19 vaccines, aprubado na ng US FDA

play

2nd booster dose ng Pfizer-BioNTech at Moderna COVID-19 vaccines, aprubado na ng US FDA

#UlatBayan | Norway: Mga namatay na binigyan ng Pfizer COVID-19 vaccine, nasa edad 80 pataas at may malubhang karamdaman; FDA, handang bawiin ang EUA ng Pfizer sakaling lumabas na may masama itong epekto sa kalusugan

play

#UlatBayan | Norway: Mga namatay na binigyan ng Pfizer COVID-19 vaccine, nasa edad 80 pataas at may malubhang karamdaman; FDA, handang bawiin ang EUA ng Pfizer sakaling lumabas na may masama itong epekto sa kalusugan

Vaccine expert: Pfizer COVID-19 vaccine, safe and effective para sa edad 5 pababa ayon sa US FDA

play

Vaccine expert: Pfizer COVID-19 vaccine, safe and effective para sa edad 5 pababa ayon sa US FDA

FDA, hinihintay na lamang ang Pfizer na mag-apply para sa full authorization ng COVID-19 vaccine; bilang ng mga nais magpabakuna vs. COVID-19, tumaas sa 53% batay sa survey ng OCTA Research

play

FDA, hinihintay na lamang ang Pfizer na mag-apply para sa full authorization ng COVID-19 vaccine; bilang ng mga nais magpabakuna vs. COVID-19, tumaas sa 53% batay sa survey ng OCTA Research

Pfizer Asks for COVID-19 Booster Shot Approval, FDA Rejects Plan

play

Pfizer Asks for COVID-19 Booster Shot Approval, FDA Rejects Plan

Pfizer and Biontech submit request to FDA for updated COVID booster shot for children

play

Pfizer and Biontech submit request to FDA for updated COVID booster shot for children

FDA Approves Moderna and Pfizer COVID Boosters for Omicron and Variants

play

FDA Approves Moderna and Pfizer COVID Boosters for Omicron and Variants

Pfizer Bivalent COVID-19 vaccine, binigyan ng FDA ng 5-yr Certificate of Product Registration | 24 Oras

play

Pfizer Bivalent COVID-19 vaccine, binigyan ng FDA ng 5-yr Certificate of Product Registration | 24 Oras

FDA To Discuss Emergency Authorization For Pfizer COVID-19 Vaccine

play

FDA To Discuss Emergency Authorization For Pfizer COVID-19 Vaccine

FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine

play

FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine